FGF pathway genes, including FGF3, FGF4 and FGF8, are common targets of MMTV integration [42,43] and FGFR3 mutations have been reported in 41% of bladder cancers [44]. This evidence concerns the gene FGF3 and urinary bladder carcinoma.